SCHEMBL3672852

SCHEMBL3672852

CCC1CCCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(Cl)nc2n1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MTOR P42345 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3672854 1.00 MTOR (0.77) MTOR
SCHEMBL2905795 0.87 MTOR (1.00) MTOR
SCHEMBL1218075 0.86 MTOR (0.58) MTOR
SCHEMBL392081 0.85 MTOR (0.72) MTOR
SCHEMBL392080 0.85 MTOR (0.72) MTOR
SCHEMBL30363612 0.85 MTOR (0.72) MTOR
SCHEMBL30405767 0.85 MTOR (0.72) MTOR
SCHEMBL393314 0.85 MTOR (0.72) MTOR
SCHEMBL8214027 0.85 MTOR (0.72) MTOR
SCHEMBL391915 0.81 MTOR (0.74) MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262504-A1 COMBINATION THERAPY 238 AstraZeneca AB (SE) 2010-12-22 EP disclosed
WO-2009104019-A1 COMBINATION THERAPY 238 ASTRAZENECA AB (SE) 2009-08-27 WO disclosed